168 related articles for article (PubMed ID: 15205264)
1. Exacerbation of autoantibody-mediated thrombocytopenic purpura by infection with mouse viruses.
Musaji A; Cormont F; Thirion G; Cambiaso CL; Coutelier JP
Blood; 2004 Oct; 104(7):2102-6. PubMed ID: 15205264
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of autoantibody pathogenicity by viral infections in mouse models of anemia and thrombocytopenia.
Musaji A; Meite M; Detalle L; Franquin S; Cormont F; Préat V; Izui S; Coutelier JP
Autoimmun Rev; 2005 Apr; 4(4):247-52. PubMed ID: 15893720
[TBL] [Abstract][Full Text] [Related]
3. Antibody-independent thrombocytopenia in lactate dehydrogenase-elevating virus-infected mice.
Su D; Musaji A; Legrain S; Detalle L; van der Kaa J; Verbeek JS; Ryffel B; Coutelier JP
J Virol; 2012 Nov; 86(22):12414-6. PubMed ID: 22933286
[TBL] [Abstract][Full Text] [Related]
4. The isotype of autoantibodies influences the phagocytosis of antibody-coated platelets in autoimmune thrombocytopenic purpura.
Hoemberg M; Stahl D; Schlenke P; Sibrowski W; Pachmann U; Cassens U
Scand J Immunol; 2011 Nov; 74(5):489-95. PubMed ID: 21790706
[TBL] [Abstract][Full Text] [Related]
5. Treatment with liposome-encapsulated clodronate as a new strategic approach in the management of immune thrombocytopenic purpura in a mouse model.
Alves-Rosa F; Stanganelli C; Cabrera J; van Rooijen N; Palermo MS; Isturiz MA
Blood; 2000 Oct; 96(8):2834-40. PubMed ID: 11023519
[TBL] [Abstract][Full Text] [Related]
6. Platelet activation induced by an antiplatelet autoantibody against CD9 antigen and its inhibition by another autoantibody in immune thrombocytopenic purpura.
Yanabu M; Nomura S; Fukuroi T; Suzuki M; Kawakatsu T; Kido H; Yamaguchi K; Kokawa T; Yasunaga K
Br J Haematol; 1993 Aug; 84(4):694-701. PubMed ID: 8217830
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet antibody-induced thrombocytopenia does not correlate with megakaryocyte abnormalities in murine immune thrombocytopenia.
Guo L; Kapur R; Aslam R; Hunt K; Hou Y; Zufferey A; Speck ER; Rondina MT; Lazarus AH; Ni H; Semple JW
Scand J Immunol; 2018 Jul; 88(1):e12678. PubMed ID: 29855061
[TBL] [Abstract][Full Text] [Related]
8. Serum from half of patients with immune thrombocytopenia trigger macrophage phagocytosis of platelets.
Norris PAA; Tawhidi Z; Sachs UJ; Cserti-Gazdewich CM; Lin Y; Callum J; Gil Gonzalez L; Shan Y; Branch DR; Lazarus AH
Blood Adv; 2023 Jul; 7(14):3561-3572. PubMed ID: 37042934
[TBL] [Abstract][Full Text] [Related]
9. Possible presence of enhancing antibodies in idiopathic thrombocytopenic purpura.
Yang YY; Fischer P; Leu SJ; Zhu M; Woods VL; Chen PP
Br J Haematol; 1999 Jan; 104(1):69-80. PubMed ID: 10027714
[TBL] [Abstract][Full Text] [Related]
10. Development and characterization of monoclonal antiplatelet autoantibodies from autoimmune thrombocytopenic purpura-prone (NZW x BXSB)F1 mice.
Mizutani H; Engelman RW; Kurata Y; Ikehara S; Good RA
Blood; 1993 Aug; 82(3):837-44. PubMed ID: 8338948
[TBL] [Abstract][Full Text] [Related]
11. Critical role of CD4(+)CD25(+) regulatory T cells in preventing murine autoantibody-mediated thrombocytopenia.
Nishimoto T; Satoh T; Takeuchi T; Ikeda Y; Kuwana M
Exp Hematol; 2012 Apr; 40(4):279-89. PubMed ID: 22240606
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein enhances IgG-mediated phagocyte responses and thrombocytopenia.
Kapur R; Heitink-Pollé KM; Porcelijn L; Bentlage AE; Bruin MC; Visser R; Roos D; Schasfoort RB; de Haas M; van der Schoot CE; Vidarsson G
Blood; 2015 Mar; 125(11):1793-802. PubMed ID: 25548320
[TBL] [Abstract][Full Text] [Related]
13. Investigation of antibody-coated liposomes as a new treatment for immune thrombocytopenia.
Deng R; Balthasar JP
Int J Pharm; 2005 Nov; 304(1-2):51-62. PubMed ID: 16171959
[TBL] [Abstract][Full Text] [Related]
14. Mouse immune thrombocytopenia is associated with Th1 bias and expression of activating Fcγ receptors.
Nishimoto T; Okazaki Y; Numajiri M; Kuwana M
Int J Hematol; 2017 May; 105(5):598-605. PubMed ID: 28028748
[TBL] [Abstract][Full Text] [Related]
15. Human/BALB radiation chimera engrafted with splenocytes from patients with idiopathic thrombocytopenic purpura produce human platelet antibodies.
Dekel B; Marcus H; Shenkman B; Shimoni A; Shechter Y; Canaan A; Berrebi A; Varon D; Reisner Y
Immunology; 1998 Jul; 94(3):410-6. PubMed ID: 9767425
[TBL] [Abstract][Full Text] [Related]
16. The pathogenesis of chronic immune (idiopathic) thrombocytopenic purpura.
McMillan R
Semin Hematol; 2000 Jan; 37(1 Suppl 1):5-9. PubMed ID: 10676917
[TBL] [Abstract][Full Text] [Related]
17. Discrepancy between antiplatelet antibody activities detected by immunoblot procedure and platelet counts in idiopathic thrombocytopenic purpura.
Matsumoto M; Takada K; Kameoka H; Hato T; Shiosaka T; Fujita S; Kobayashi Y
Jpn J Med; 1991; 30(1):10-4. PubMed ID: 1865569
[TBL] [Abstract][Full Text] [Related]
18. The effect of antiplatelet autoantibodies on megakaryocytopoiesis.
McMillan R; Nugent D
Int J Hematol; 2005 Feb; 81(2):94-9. PubMed ID: 15765775
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet antibodies in chronic immune thrombocytopenia and their role in platelet destruction and defective platelet production.
McMillan R
Hematol Oncol Clin North Am; 2009 Dec; 23(6):1163-75. PubMed ID: 19932426
[TBL] [Abstract][Full Text] [Related]
20. Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP).
Najaoui A; Bakchoul T; Stoy J; Bein G; Rummel MJ; Santoso S; Sachs UJ
Eur J Haematol; 2012 Feb; 88(2):167-74. PubMed ID: 21985182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
